U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07338214) titled 'Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations' on Dec. 11, 2025.
Brief Summary: This clinical research study is testing the study compound petrelintide that is being developed for the weight management in people with obesity or overweight with co-morbidities or related diseases.
The goal is to learn how the same single dose of petrelintide, given using different concentrations, works in the body when given to participants with a BMI at, or above, 27kg/m2.
The main questions it aims to answer are:
1. Are there differences in how the body absorbs, distributes, metabolises and excrete...